| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042638253 |
| P356 | DOI | 10.1038/455178A |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/455178a |
| P698 | PubMed publication ID | 18784712 |
| P50 | author | James R. Lupski | Q6141679 |
| P2860 | cites work | Rare chromosomal deletions and duplications increase risk of schizophrenia | Q22337245 |
| Strong association of de novo copy number mutations with autism | Q24633543 | ||
| Large recurrent microdeletions associated with schizophrenia | Q24654741 | ||
| Identifying autism loci and genes by tracing recent shared ancestry | Q24655308 | ||
| Association between microdeletion and microduplication at 16p11.2 and autism | Q28264205 | ||
| Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia | Q28274064 | ||
| Strong association of de novo copy number mutations with sporadic schizophrenia | Q28282047 | ||
| Psychiatric genetics: progress amid controversy | Q28284253 | ||
| Recurrent 16p11.2 microdeletions in autism | Q34729775 | ||
| A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures | Q36627230 | ||
| Genomic rearrangements and sporadic disease | Q36863512 | ||
| DNA duplication associated with Charcot-Marie-Tooth disease type 1A | Q68308484 | ||
| Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits | Q77572380 | ||
| P433 | issue | 7210 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 178-179 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Schizophrenia: Incriminating genomic evidence | |
| P478 | volume | 455 |
| Q92229368 | 2018 Victor A. McKusick Leadership Award: Molecular Mechanisms for Genomic and Chromosomal Rearrangements |
| Q27333802 | A duplication CNV that conveys traits reciprocal to metabolic syndrome and protects against diet-induced obesity in mice and men |
| Q33539809 | A recombination hotspot in a schizophrenia-associated region of GABRB2 |
| Q24632941 | CNV and nervous system diseases--what's new? |
| Q36851578 | Clan genomics and the complex architecture of human disease |
| Q42495293 | Cognitive phenotypes and genomic copy number variations |
| Q35731269 | Complex human chromosomal and genomic rearrangements |
| Q34019142 | Copy number variation in human health, disease, and evolution |
| Q40510522 | Epigenetic Regulation in Amyloid Precursor Protein with Genomic Rearrangements and the Lesch-Nyhan Syndrome |
| Q24610261 | Evolutionary history and genome organization of DUF1220 protein domains |
| Q41029169 | Exome sequencing and arrayCGH detection of gene sequence and copy number variation between ILS and ISS mouse strains |
| Q35178106 | Finished sequence and assembly of the DUF1220-rich 1q21 region using a haploid human genome |
| Q30000781 | Fusion of large-scale genomic knowledge and frequency data computationally prioritizes variants in epilepsy |
| Q37198442 | Genomic disorders ten years on. |
| Q28302565 | Genomic duplication resulting in increased copy number of genes encoding the sister chromatid cohesion complex conveys clinical consequences distinct from Cornelia de Lange |
| Q30454958 | Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery |
| Q55115610 | Opposing phenotypes in mice with Smith-Magenis deletion and Potocki-Lupski duplication syndromes suggest gene dosage effects on fluid consumption behavior. |
| Q27691419 | Structural variation mutagenesis of the human genome: Impact on disease and evolution |
| Q34236086 | The molecular pathology of schizophrenia--focus on histone and DNA modifications |
Search more.